Skip to content
Search AI Powered

Latest Stories

Government accepts JCVI advice on COVID-19 and flu vaccination programmes

Government accepts JCVI advice on COVID-19 and flu vaccination programmes

The government will continue to provide COVID-19 vaccinations to frontline health and social care staff and care home workers in the autumn 2024 programme

The government has accepted the Joint Committee on Vaccination and Immunisation's (JCVI) advice for the autumn 2024 COVID-19 vaccination programme.


According to the JCVI, the following groups will be eligible for vaccination this autumn:

  • Individuals aged 65 and over
  • Residents of care homes for older adults
  • Those aged 6 months and older in clinical risk groups

Minister for Public Health and Prevention, Andrew Gwynne, emphasised the importance of protecting vulnerable populations from COVID-19 and reducing pressure on the NHS.

He said: “We are committed to protecting those most vulnerable from COVID and have accepted the independent advice from the JCVI for the autumn 2024 vaccination programme.”

“I encourage anyone invited for a vaccine to get one as soon as possible to protect yourself and reduce pressure on the NHS during winter, helping to cut waiting times and get the health service back on its feet.”

Additionally, Gwynne announced that the government will continue to offer COVID-19 vaccinations to frontline NHS and social care workers and staff in care homes for older people this autumn.

The JCVI did not recommend including frontline health and social care workers, staff in care homes for older adults, unpaid carers, and household contacts of immunosuppressed individuals in the national programme.

The JCVI suggested that health and social care service providers consider setting up an occupational health vaccination programme for frontline workers, similar to the existing flu vaccine programme.

However, since implementing a new occupational health programme before autumn 2024 is not feasible, the JCVI recommended that health departments might opt to continue offering vaccinations through the national programme this autumn.

Consequently, the government has decided to maintain the provision of COVID-19 vaccinations to frontline health and social care staff, as well as staff working in care homes for older people, in the autumn 2024 programme.

Earlier, the JCVI advised NHS England to move the start of the flu vaccination programme for most adults to the beginning of October.

This change is based on evidence showing that the flu vaccine’s effectiveness can decrease over time in adults.

The goal is to complete the majority of vaccinations by the end of November, aligning more closely with the start of the flu season.

Bases on this advice, NHS England has confirmed the following start dates for the commencement of the service for pharmacies and general practices:

  • 1st September 2024: Pregnant women
  • 3rd October 2024: All other eligible adult patients

In previous years, flu vaccinations have been offered from September.

The NHS will not cover the cost of vaccinations administered outside these specified dates.

Pharmacy teams should inform their patients about the later start to the programme and the reasons behind NHS England's decision.

Community Pharmacy England has developed a poster to help communicate this information in pharmacies.

More For You

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Prakash Patel was speaking at a panel discussion at the Sigma Conference

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Pharmacists need to be a part of integrated care boards (ICB) to stop GPs from monopolising services based on their needs rather than the needs of the patient, according to Prakash Patel, Community Pharmacy Engaland (CPE) representative for North London.

“The evolution of the NHS should mean there can be no decision of pharmacy without pharmacist,” Patel told delegates at the Sigma Pharmacy Conference in Baku, Azerbaijan on Tuesday.

Keep ReadingShow less
New professional liability insurance policy for RPS members launched

The insurance will be provided to members at cost, with no profit made by RPS.

gettyimages

RPS launches professional liability insurance for members

The Royal Pharmaceutical Society (RPS) has launched a new professional liability insurance policy, designed to empower pharmacists to work confidently and deliver high-quality care, knowing they are protected.

Exclusively available to its members, the comprehensive and affordable insurance has been developed in collaboration with global professional services firm Aon.

Keep ReadingShow less
Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less